146 related articles for article (PubMed ID: 25752716)
1. Neurotrophin receptors and perineural invasion in desmoplastic melanoma.
Frydenlund N; Leone DA; Mitchell B; Yang S; Deng A; Hoang MP; Mahalingam M
J Am Acad Dermatol; 2015 May; 72(5):851-8. PubMed ID: 25752716
[TBL] [Abstract][Full Text] [Related]
2. Desmoplastic melanoma, neurotropism, and neurotrophin receptors--what we know and what we do not.
Frydenlund N; Mahalingam M
Adv Anat Pathol; 2015 Jul; 22(4):227-41. PubMed ID: 26050260
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver?
Kadokura A; Frydenlund N; Leone DA; Yang S; Hoang MP; Deng A; Hernandez-Perez M; Biswas A; Singh R; Yaar R; Mahalingam M
Hum Pathol; 2016 Jul; 53():82-90. PubMed ID: 26980030
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophin Receptors and Perineural Invasion: Analyses in Select Lineage-Unrelated Cutaneous Malignancies With a Propensity for Perineural Invasion.
Frydenlund NF; Mahalingam M
Vitam Horm; 2017; 104():497-531. PubMed ID: 28215306
[TBL] [Abstract][Full Text] [Related]
5. Perineural invasion in cutaneous squamous cell carcinoma: role of immunohistochemistry, anatomical site, and the high-affinity nerve growth factor receptor TrkA.
Frydenlund N; Leone DA; Mitchell B; Abbas O; Dhingra J; Mahalingam M
Hum Pathol; 2015 Aug; 46(8):1209-16. PubMed ID: 26072357
[TBL] [Abstract][Full Text] [Related]
6. p75(NGFR) immunostaining for the detection of perineural invasion by cutaneous squamous cell carcinoma.
Lewis Kelso R; Colome-Grimmer MI; Uchida T; Wang HQ; Wagner RF
Dermatol Surg; 2006 Feb; 32(2):177-83. PubMed ID: 16442036
[TBL] [Abstract][Full Text] [Related]
7. Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal.
Miller DD; Emley A; Yang S; Richards JE; Lee JE; Deng A; Hoang MP; Mahalingam M
Mod Pathol; 2012 Apr; 25(4):505-15. PubMed ID: 22157936
[TBL] [Abstract][Full Text] [Related]
8. Functional RET G691S polymorphism in cutaneous malignant melanoma.
Narita N; Tanemura A; Murali R; Scolyer RA; Huang S; Arigami T; Yanagita S; Chong KK; Thompson JF; Morton DL; Hoon DS
Oncogene; 2009 Aug; 28(34):3058-68. PubMed ID: 19561646
[TBL] [Abstract][Full Text] [Related]
9. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
10. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: is there an association with perineural invasion?
Kolokythas A; Cox DP; Dekker N; Schmidt BL
J Oral Maxillofac Surg; 2010 Jun; 68(6):1290-5. PubMed ID: 20363547
[TBL] [Abstract][Full Text] [Related]
12. Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome.
Lawrence NF; Hammond MR; Frederick DT; Su Y; Dias-Santagata D; Deng A; Selim MA; Mahalingam M; Flaherty KT; Hoang MP
J Am Acad Dermatol; 2016 Sep; 75(3):595-602. PubMed ID: 27543214
[TBL] [Abstract][Full Text] [Related]
13. Perineural Invasion Is an Independent Pathologic Indicator of Recurrence in Vulvar Squamous Cell Carcinoma.
Holthoff ER; Jeffus SK; Gehlot A; Stone R; Erickson SW; Kelly T; Quick CM; Post SR
Am J Surg Pathol; 2015 Aug; 39(8):1070-4. PubMed ID: 25786085
[TBL] [Abstract][Full Text] [Related]
14. Defining incidental perineural invasion: the need for a national registry.
Buchanan L; De'Ambrosis B; DeAmbrosis K; Warren T; Huilgol S; Soyer HP; Panizza B
Australas J Dermatol; 2014 May; 55(2):107-10. PubMed ID: 24372092
[TBL] [Abstract][Full Text] [Related]
15. Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer.
Dang C; Zhang Y; Ma Q; Shimahara Y
J Gastroenterol Hepatol; 2006 May; 21(5):850-8. PubMed ID: 16704535
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
[TBL] [Abstract][Full Text] [Related]
17. Nerve Growth Factor Signals as Possible Pathogenic Biomarkers for Perineural Invasion in Adenoid Cystic Carcinoma.
Kobayashi K; Ando M; Saito Y; Kondo K; Omura G; Shinozaki-Ushiku A; Fukayama M; Asakage T; Yamasoba T
Otolaryngol Head Neck Surg; 2015 Aug; 153(2):218-24. PubMed ID: 25968060
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Perineural Invasion in Cutaneous Squamous Cell Carcinoma: Results of a Prospective Study of 1,399 Tumors.
Haug K; Breuninger H; Metzler G; Eigentler T; Eichner M; Häfner HM; Schnabl SM
J Invest Dermatol; 2020 Oct; 140(10):1968-1975. PubMed ID: 32169476
[TBL] [Abstract][Full Text] [Related]
20. Perineural infiltration of cutaneous squamous cell carcinoma and basal cell carcinoma without clinical features.
Lin C; Tripcony L; Keller J; Poulsen M; Martin J; Jackson J; Dickie G
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):334-40. PubMed ID: 21093171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
